Liver transplantation (LT) is the treatment of choice for early hepatocellular carcinoma (HCC) in patients with end-stage liver disease but is limited by the availability of donor organs. Living donor liver transplantation (LDLT) represents an alternative therapeutic option for patients with disease
Living donor liver transplantation for hepatocellular carcinoma: a single center analysis of outcomes and impact of different selection criteria
β Scribed by Deniz Balci; Murat Dayangac; Onur Yaprak; Baris Akin; Cihan Duran; Refik Killi; Yildiray Yuzer; Yaman Tokat
- Book ID
- 110917639
- Publisher
- Springer
- Year
- 2011
- Tongue
- English
- Weight
- 394 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0934-0874
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
In the present study, the results of living donor liver transplantation (LDLT) for 125 hepatocellular carcinoma (HCC) patients were analyzed to determine optimal criteria exceeding the Milan criteria (MC) but still with predictably good outcomes. On the basis of pretransplant imaging studies, 70 pat
The currently available indication criteria of living donor liver transplantation (LDLT) for patients with hepatocellular carcinoma (HCC) have high prognostic power but insufficient discriminatory power. On the basis of single-center results from 221 HCC patients undergoing LDLT, we modified the ind